*Pediatric Investigation* (PI) is a new open‐access pediatric medical journal, which is published in English quarterly online as well as in printed form. The editorial board of PI is consisted of 25 international and 32 domestic pediatric experts. Our co‐editors‐in‐chief (one international and one domestic), associate editors (9 international and 5 domestic), and editorial board members are pediatric experts from well‐known pediatric hospitals/departments of the world. I believe that this new pediatric journal will successfully achieve all its goals mentioned by Prof. Burns in his editorial[1](#ped412003-bib-0001){ref-type="ref"} with the support and help from all the experts and our readers and authors. I hope that this new pediatric journal would be able to make certain minor differences in its work in addition to its major mission, reporting the high‐quality high‐level clinical, basic, and translational research articles.

A journal\'s tasks may include reporting, interaction, and education. For reporting original research, we encourage both clinical and basic research while prospective rigorously designed randomized clinical trials and other types of studies that can provide potent and reliable evidences may be more emphasized. Translational and basic science studies that have higher possibility for clinical application will also be highly encouraged. On the other hand, in China and some other countries, there are traditional, alternative, or supplementary medical practice. Clinical studies on the efficacy and safety of such practice applying principles and methodology of modern clinical trials will also be encouraged and considered. We will make efforts to increase exchanges and communications between the eastern and the western thoughts, approaches, and practice in pediatric medicine and health care.

For interaction among authors, readers, and editors, we will set up some different columns and article types to provide platforms for exchanges and discussions in a wide range of pediatric care and relevant fields to promote understanding, learning, and creativity. Well‐organized debates on important topics may be helpful to reach further understanding and final agreement. Appropriate communication between patients/parents and editor/caregivers may be beneficial to better patient care. Timely correspondence between readers and authors, readers and editors, and authors and editors will help improve the quality of the publication and solve certain problems.

For education, clinical trial will be listed as one of the most important topics, since in China, and possibly in some other developing countries, clinical trials in pediatrics need much more work to reach the levels of developed countries where the pediatric researchers and relevant sectors have provided excellent paradigms[2](#ped412003-bib-0002){ref-type="ref"}, [3](#ped412003-bib-0003){ref-type="ref"} for pediatric clinical trials and timely and rational use of new therapies in pediatric patient population. Unlike in the United States and Europe, very limited number of articles on pediatric clinical trials have been published in international medical journals by authors of the inland of China.[4](#ped412003-bib-0004){ref-type="ref"} Many or most of clinical trials have not enrolled children because of the concerns about their safety. As a result, for many of the novel therapeutic approaches, there are no data about clinical use in children\'s population, and therefore, many of the pediatric patients lost the opportunity of receiving such new drugs/therapies. Off‐label uses of new drugs for pediatric patients do occur often, and this may expose the patients to risks of adverse or severe adverse events.

We plan to organize intensified seminars/workshops in addition to publishing lectures, discussions written by experienced clinical trialists, and experts from different fields, including medical ethics and statistics. PI editorial office determined to make joint efforts with all the experts who support such education to popularize knowledge and expertise from basic principles of clinical trials, how to select important research topics, to correct and rigorous study design, blinding (double blind or single blind) trials, and keeping the design blinded during the whole study, how to organize multicenter trials with sufficiently representative subjects, how to collect, store, protect, and analyze data, and how to prepare manuscripts in English for different types of clinical studies, and finally, submission and publishing manuscripts.

We also will seek for approaches to solve some problems that may hinder development of pediatrics and pediatric care in China as well as in other countries. Shortage of pediatric professionals is a problem. The ratio of the number of pediatricians to the number of children in China was estimated to be 0.43 in 1000 children, but in the United States, the ratio is 1.36. The total number of children in China was estimated to be 360 million. To reach the ratio of the United States, at least as many as 100 000 additional pediatricians are needed.[5](#ped412003-bib-0005){ref-type="ref"}

The internationally and nationally existing and accepted publication ethics and policies, and the requirements for biomedical journal manuscripts, including the clinical trial registration and the recently proposed requirement of data sharing by the International Committee of Medical Journal Editors (ICMJE)[6](#ped412003-bib-0006){ref-type="ref"}, are all essential for reporting best peer‐reviewed research achievements and finally for providing high‐quality, reliable evidences for best pediatric clinical care. PI will support and follow these requirements and policies.

We hope PI would finally become a readers‐friendly, authors‐friendly, useful, and helpful journal of pediatric professionals.
